Insider Cluster (3 insiders) ·Filed May 26, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $0.2M total
Actionable Insight • Neutral

This cluster is routine and non-informative. The CEO's cashless exercise is standard post-vesting liquidity management. With only 0.05% of market cap sold and no C-suite cluster buying, there is no actionable signal. Monitor for any upcoming material news (earnings, pipeline updates) that could explain the timing, but the dollar amounts are too small to warrant a trade.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
RCKT ▲ +16.39% at T+60d
NEUTRAL call ✓ call won +16.39% · α vs SPY +14.51% · entry $2.99 → $3.48
Entry anchored
May 26, 2026
via day open
T+1d
+1.00%
call +1.00% · α +0.45%
$3.02
settled 4mo ago
T+5d
-2.34%
call -2.34% · α -2.81%
$2.92
settled 4mo ago
T+20d
+8.36%
call +8.36% · α +10.26%
$3.24
settled 3mo ago
T+60d
+16.39%
call +16.39% · α +14.51%
$3.48
settled 6w ago

Price Chart

Loading chart...

Executive Summary

CEO Gaurav Shah exercised 76,490 options at $1.69 and immediately sold 55,684 shares on the open market for ~$172K, a classic cashless exercise pattern. Two other executives sold small amounts ($1K-$2K) at $3.01. Total cluster sales of $175K represent ~0.05% of market cap — trivial in size. The CEO's sale is likely liquidity-driven (tax withholding or diversification) rather than a bearish signal, especially given the small dollar amount relative to market cap.

Key Financial Metrics

Direction
selling
Total Value
$175.0K
Insiders
3

Key Facts

  • CEO Gaurav Shah exercised 76,490 options at $1.69 and sold 55,684 shares at $3.09 for ~$172K on 2026-05-21
  • Two other executives (John Militello, Martin Wilson) sold 384 and 662 shares respectively at $3.01 for ~$1K each
  • Total cluster sale value of ~$175K is 0.05% of $323M market cap — well below the 0.1% materiality threshold
  • CEO's sale is a cashless exercise pattern (exercise + immediate sale to cover cost/taxes) — not a directional bearish signal
  • No open-market purchases in the cluster; all three transactions are sales

Financial Impact

Total insider sales of ~$175K, representing 0.05% of market cap — immaterial

insider holdingsdilution

Risk Factors

  • CEO's option exercise adds 76,490 shares to the float, but this is minimal dilution (~0.1% of shares outstanding)
  • No insider buying to offset the sales — consistent with a neutral stance, not bearish

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
55% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RCKT-1779839259223
12 reports for RCKT
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +42.18%Jun 12, 2026
Filters
Rows
Reports for RCKT — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
BULLISH ★ 7/10
$3.41 $3.35▼ −1.76%▼ −3.89%$2.56 (−24.93%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.48 $3.62▲ +4.02%▲ +2.91%$2.56 (−26.44%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.34 $3.78▲ +13.17%▲ +13.37%$2.56 (−23.35%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.34 $3.48▲ +4.04%▲ +6.01%$2.56 (−23.35%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 7/10
$3.50 $3.34▼ −4.57%▼ −4.17%$2.56 (−26.86%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 6/10
$3.41 $3.64▲ +6.74%▲ +4.72%$2.56 (−24.93%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$3.52 $4.07▲ +15.63%▲ +15.36%$2.56 (−27.27%)
Jun 12, 2026
16w ago
8-K
BULLISH ★ 5/10
$2.75 $3.35▲ +21.82%▲ +21.15%$2.56 (−6.91%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.99 $2.92▼ −2.34%▼ −2.81%$2.56 (−14.38%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.25 $2.96▼ −8.92%▼ −9.89%$2.56 (−21.23%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 26, 2026